Scheme 1. Synthesis of DIMAC
azides without compromising selectivity in biological sys-
tems.4 Since the initial report, fluorination5 and fused phenyl
rings6 have improved the reaction kinetics, and a difluori-
nated analogue has been employed to image glycans in
developing zebrafish.7
zinc reduction/reductive amination reaction followed by
amide formation with methyl succinyl chloride.10 The eight-
membered ring was generated by a Grubbs ring-closing
metathesis reaction to yield 3.11 Allylic alcohol 3 was
converted to ketone 4 via oxidation to the enone followed
by hydrogenation.
We explored two routes for conversion of the ketone to
the corresponding alkyne: vinyl triflate formation followed
by syn-elimination of triflic acid5 and formation of a
selenadiazole followed by fragmentation to the alkyne.12
Although successful in our previous cyclooctyne syntheses,5
the vinyl triflate method proved too harsh for the target
compound. Thus, we condensed compound 4 with semicar-
bazide and oxidized the resulting intermediate to yield
selenadiazole 5. Subsequent thermal decomposition of the
selenadiazole followed by saponification of the methyl ester
produced DIMAC (6).
The reactivity of DIMAC was tested in a model 1,3-dipolar
cycloaddition reaction with benzyl azide (Scheme S2,
Supporting Information). The reaction proceeded cleanly with
a second-order rate constant of 3.0 × 10-3 M-1 s-1 (Figure
S1, Supporting Information), slightly higher than that for the
parent cyclooctynes (1-2 × 10-3 M-1s-1).4,5a This slight
enhancement in rate might reflect added ring strain due to
the shorter C-N bond length or the sp2 character of the
amide nitrogen.13
These achievements reflect optimization of the reaction
for use with live cells and simple model organisms. However,
we envision applications of Cu-free click chemistry in
mammalian disease models where the bioavailability and
pharmacokinetic properties of the reagents become important.
The cyclooctynes currently employed for Cu-free click
chemistry comprise hydrocarbon scaffolds that limit their
solubility in aqueous solutions. The hydrophobicity of these
cyclooctyne scaffolds could also promote sequestration by
membranes or nonspecific binding to serum proteins, thereby
reducing their bioavailable concentrations. Consequently, we
have focused on designing strained cycloalkynes with
enhanced water solubility.
Here, we report the synthesis and biological evaluation
of a novel heterocyclic and heteroatom-substituted cyclooc-
tyne. The compound, 6,7-dimethoxyazacyclooct-4-yne
(DIMAC, Figure 1B), has a nitrogen atom within the strained
ring system that interrupts the hydrophobic surface area and
provides a convenient site for probe conjugation. We
reasoned that two methoxy groups would enhance the
compound’s polarity, and placement of one at the propargylic
position would impart reaction kinetics similar to existing
simple cyclooctynes.4,5a LogS calculations for DIMAC
methyl amide gave a value of ∼-2.7, while that of a parent
cyclooctyne methyl amide was ∼-3.1.8
Next, we tested the ability of DIMAC to label glycan-
associated azides within cell lysates and on the surface of
live cells. DIMAC was first conjugated to biotin (Figure 2A;
(8) Calculated for compounds 7 and 8 where R ) CH3 using logS
negative values indicate poorer water solubility. (a) Tetko, I. V.; Tanchuk,
V. Y.; Kasheva, T. N.; Villa, A. E. J. Chem. Inf. Comput. Sci. 2001, 41,
246–252. (b) Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. P.
J. Chem. Inf. Comput. Sci. 2001, 41, 1488–1493.
As shown in Scheme 1, DIMAC was synthesized in nine
steps beginning from methyl 6-bromoglucopyranoside (1).9
First, compound 1 was transformed to acyclic diene 2 via a
(5) (a) Agard, N. J.; Baskin, J. M.; Prescher, J. A.; Lo, A.; Bertozzi,
C. R. ACS Chem. Biol. 2006, 1, 644–648. (b) Baskin, J. M.; Prescher, J. A.;
Laughlin, S. T.; Agard, N. J.; Chang, P. V.; Miller, I. A.; Lo, A.; Codelli,
J. A.; Bertozzi, C. R. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 16793–
16797.
(9) (a) Jones, K.; Wood, W. W. Carbohydr. Res. 1986, 155, 217–222.
(b) Scheme S1, Supporting Information.
(10) Sletten, E. M.; Liotta, L. J. J. Org. Chem. 2006, 71, 1335–1343.
(11) Miller, S. J.; Kim, S. H.; Chen, Z. R.; Grubbs, R. H. J. Am. Chem.
Soc. 1995, 117, 2108–2109.
(6) Ning, X.; Guo, J.; Wolfert, M. A.; Boons, G-J. Angew. Chem., Int.
Ed. 2008, 47, 2253–2255.
(12) (a) Meier, H.; Voigt, E. Tetrahedron 1972, 28, 187–198. (b) Meier,
H.; Stavridou, E.; Storek, C. Angew. Chem., Int. Ed. 1986, 9, 809–810. (c)
Petersen, H.; Kolshorn, H.; Meier, H. Angew. Chem., Int. Ed. 1978, 17,
461–462.
(7) Laughlin, S. T.; Baskin, J. M.; Amacher, S. L.; Bertozzi, C. R.
Science 2008, 320, 664–667.
3098
Org. Lett., Vol. 10, No. 14, 2008